相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Donor Lymphocyte Infusions Modulate Relapse Risk in Mixed Chimeras and Induce Durable Salvage in Relapsed Patients After T-Cell-Depleted Allogeneic Transplantation for Hodgkin's Lymphoma
Karl S. Peggs et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
T-Cell-Depleted Reduced-Intensity Transplantation Followed by Donor Leukocyte Infusions to Promote Graft-Versus-Lymphoma Activity Results in Excellent Long-Term Survival in Patients With Multiply Relapsed Follicular Lymphoma
Kirsty J. Thomson et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Donor lymphocyte infusion for leukemia relapse after hematopoietic stem cell transplantation
Zeynep Arzu Yegin et al.
TRANSFUSION AND APHERESIS SCIENCE (2010)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation
M. R. Bishop et al.
ANNALS OF ONCOLOGY (2008)
High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma
Adrian J. C. Bloor et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population
J. E. Levine et al.
BONE MARROW TRANSPLANTATION (2008)
Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation
A. W. Loren et al.
BONE MARROW TRANSPLANTATION (2008)
Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes
Karl S. Peggs et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions
CA Huff et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma
N. W. C. J. van de Donk et al.
BONE MARROW TRANSPLANTATION (2006)
Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia
JG Gribben et al.
BLOOD (2005)
Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation
NH Russell et al.
BONE MARROW TRANSPLANTATION (2005)
Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective study
SJ Choi et al.
BONE MARROW TRANSPLANTATION (2005)
Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation
KS Peggs et al.
LANCET (2005)
Outcome and long-term follow-up of alloreactive donor lymphocyte infusions given for relapse after myeloablative allogeneic hematopoietic stem cell transplantations (HSCT)
AS Michallet et al.
BONE MARROW TRANSPLANTATION (2005)
Dose-escalated donor lymphocyte inftisions following reduced intensity transplantation: toxicity, chimerism, and disease responses
KS Peggs et al.
BLOOD (2004)
Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+cell dose, GVHD and disease response
P Anderlini et al.
BONE MARROW TRANSPLANTATION (2004)
Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma
E Morris et al.
BLOOD (2004)
The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma
HM Lokhorst et al.
BLOOD (2004)
Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status:: implications of minimal residual disease measurement with quantitative PCR
M Ritgen et al.
BLOOD (2004)
Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: Importance of allogeneic T cells
CA Huff et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: Limited efficacy of graft-versus-tumor activity
KS Peggs et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation
CMPW Mandigers et al.
BONE MARROW TRANSPLANTATION (2003)
Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation
SP Robinson et al.
BLOOD (2002)
The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation
DI Marks et al.
BLOOD (2002)
High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions
A Badros et al.
BLOOD (2001)
Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation
DL Porter et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2001)
Donor leukocyte infusions for multiple myeloma
M Salama et al.
BONE MARROW TRANSPLANTATION (2000)
Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome
S Shiobara et al.
BONE MARROW TRANSPLANTATION (2000)
Donor leukocyte infusions in acute lymphocytic leukemia
RH Collins et al.
BONE MARROW TRANSPLANTATION (2000)
Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: Predictive factors for response and long-term outcome
HM Lokhorst et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
